Article
Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.
Clinical laboratory science : journal of the American Society for Medical Technology - 1 Jan 2012
Bhaijee Feriyl, Jordan Brenda, Pepper Dominique J, Leacock Rodney, Rock William A
Abstract excerpt
Both hereditary and acquired factors increase the risk of venous thromboembolism, thus the clinical management of affected patients involves evaluation of genetic factors that predispose to hypercoagulability. Factor V Leiden (R507Q) and factor II (prothrombin) mutation (G20210A) are the two most common inherited hypercoagulability disorders among populations of European origin. Both factor V Leiden and factor II...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
